Hopefully not, I'd rather see Nova Eye reach its full potential rather than be acquired so early in its journey.
Nonetheless, there has been lots of M&A in the MIGS space recently, with one last year for a pre-revenue MIGS manufacturer that won't receive FDA approval for years fetching a price tag 15x higher than the current market cap of EYE (which is already revenue generating, and as of a few weeks ago FDA approved). Nova Eye certainly looks very cheap relative to recent comps (and therefore very appealing to big pharma/PE)
Ann: FDA Clears iTrack Advance for US Launch, page-46
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $59.49M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 25.0¢ | $41.12K | 162.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21139 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 57200 | 2 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
0.005 ( 1.96 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 26.5¢ | 25.0¢ | 37040 | ||
| Last updated 15.17pm 15/05/2024 ? | |||||
| EYE (ASX) Chart |